CHIR 99021 trihydrochloride

CHIR 99021 trihydrochloride

Catalog Number:
L002371245APE
Mfr. No.:
APE-B5779
Price:
$212
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          CHIR 99021 trihydrochloride is hydrochloride of CHIR 99021, which inhibits GSK-3α and GSK-3β with IC50 values of 10 nM and 6.7 nM. GSK-3 is a serine/threonine kinase, responsible for phosphorylating either the serine or threonine residues of its substrates. This phosphorylation process is involved in various key biological processes, including gene transcription, protein synthesis, cell signaling, cellular transport, proliferation, apoptosis, intracellular communication and glucose regulation.

          1. Ring DB, Johnson KW, Henriksen EJ, et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes, 2003, 52(3): 588-595.
          2. Pandey MK, DeGrado TR. Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. Theranostics, 2016, 6(4): 571-593.
          3. Mussmann R, Geese M, Harder F, et al. Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. Journal of Biological Chemistry, 2007, 282(16): 12030-12037.

      • Properties
        • Alternative Name
          (Z)-6-((2-((E)-(4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2(1H)-ylidene)amino)ethyl)imino)-1,6-dihydropyridine-3-carbonitrile trihydrochloride
          Molecular Formula
          C22H18Cl2N8·3HCl
          Molecular Weight
          574.72
          Appearance
          Off White solid
          Purity
          98.00%
          Solubility
          insoluble in EtOH; ≥21.87 mg/mL in DMSO; ≥32.45 mg/mL in H2O
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    ML 289

    $443

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.